My Profile

Search abstracts

Lewis Sheiner

Budapest, Hungary

Lisboa, Portugal

Hersonissos, Crete, Greece

Alicante, Spain

Glasgow, Scotland

Venice, Italy

Athens, Greece

Berlin, Germany

St. Petersburg, Russia

Marseille, France

K°benhavn, Denmark

Brugge/Bruges, Belgium

Pamplona, Spain

Uppsala, Sweden

Verona, Italy

Paris, France

Basel, Switzerland

Salamanca, Spain

Saintes, France

Wuppertal, Germany

Glasgow, Scotland

Sandwich, UK

Frankfurt, Germany

Greenford, UK

Paris, France

Basel, Switzerland

Printable version

PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe.
ISSN 1871-6032

PAGE 25 (2016) Abstr 3696 []

PDF poster/presentation:
Click to openClick to open

Poster: Methodology - New Modelling Approaches

I-23 Britta  Goebel Modeling & Simulation of Long-Term Body Weight Loss during Obesity Pharmacotherapy

Britta G÷bel (1), Stefanie Keil (1), Thomas Klabunde (1), Arjun Sanghvi (2), Joachim Tillner (1), Kevin D Hall (2)

(1) Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany; (2) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

Objectives: Obesity pharmacotherapy can lead to clinically meaningful long-term body weight loss [1]. In early Proof-of-Concept studies, drug effects on body weight are often measured for a period of few weeks only. However, the question arises how body weight changes develop over a long period of treatment, i.e., several years. This knowledge is crucial to decide early in the clinical program, if the targeted weight loss after long-term treatment can be reached. In humans, most obesity drugs work by decreasing metabolizable energy intake. However, quantification of energy intake changes during long-term obesity pharmacotherapy has been prevented by the limitations of self-report methods of measuring energy intake or extrapolation from short-term meal tests [2].

Methods: A validated mathematical model of human metabolism was used to provide the first quantification of metabolizable energy intake changes during long-term obesity pharmacotherapy using body weight data from randomized, placebo-controlled trials that evaluated 14 different drugs or drug combinations [3,4,5,6]. For novel weight reducing drug candidates with a body weight time profile only covering the first weeks of treatment, the long-term body weight loss was estimated applying a quantitative systems pharmacology model.

Results: Changes in metabolizable energy intake during obesity pharmacotherapy were reasonably well described by an exponential pattern, with early large changes in metabolizable energy intake followed by a slow transition to a smaller persistent drug effect. The high correlation between early and late drug effects on energy intake suggests that short-term data can be used to estimate long-term weight outcomes.

Conclusions: Repeated body weight measurements along with a mathematical model of human metabolism can be used to quantify changes in metabolizable energy intake during obesity pharmacotherapy. The calculated metabolizable energy intake changes followed a universal exponential pattern, and hence different drugs can be evaluated and compared using a common mathematical framework. Moreover, the described approach allows translating short-term drug effects into long-term estimations of body weight loss by means of a systems pharmacology approach.

[1] Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014;311:74-86.
[2] Schoeller DA, Thomas D, Archer E, et al. Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions. Am J Clin Nutr 2013;97:1413-1415.
[3] Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011;378:826-837.
[4] Hall KD, Chow CC. Estimating changes in free-living energy intake and its confidence interval. Am J Clin Nutr 2011;94:66-74.
[5] Sanghvi A, Redman LM, Martin CK, Ravussin E, Hall KD. Validation of an inexpensive and accurate mathematical method to measure long-term changes in free-living energy intake. Am J Clin Nutr. 2015;102(2):353-358.
[6] Goebel B, Sanghvi A, Hall KD. Quantifying Energy Intake Changes During Obesity Pharmacotherapy. Obesity 2014;22(10):2105-2108.